Saraf S - Search Results

1

Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.

Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA, Saraf S, Kamaruddin S, Gurnell E, Chapman A, Hussain S, Elliott J, Leelarathna L, Ryder REJ, Hammond P, Lumb A, Choudhary P, Wilmot EG; ABCD Closed-Loop Audit Contributors. Crabtree TSJ, et al. Among authors: saraf s. Diabetes Care. 2023 Oct 1;46(10):1831-1838. doi: 10.2337/dc23-0635. Diabetes Care. 2023. PMID: 37566697 Free PMC article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 38614603

3

Trends in rates of complications and adverse outcomes in diabetic ketoacidosis following changes to the Joint British Diabetes Societies' management guidelines.

Skaria M, Ponniah G, Birchenough A, Owen M, Pan C, Soghal S, Warmington E, Sheikh H, Karamat A, Saraf S, Kempegowda P. Skaria M, et al. Among authors: saraf s. Clin Med (Lond). 2022 Jul;22(Suppl 4):71. doi: 10.7861/clinmed.22-4-s71. Clin Med (Lond). 2022. PMID: 36220226 Free PMC article. No abstract available.

4

Significant increase in high-density lipoprotein cholesterol with fibrates is associated with low pretreatment high-density lipoprotein cholesterol: findings from an outpatient clinic setting.

Ramachandran S, Abbas A, Saraf S, Raju J, Jewkes C, Jones AF. Ramachandran S, et al. Among authors: saraf s. Metab Syndr Relat Disord. 2012 Jun;10(3):189-94. doi: 10.1089/met.2011.0112. Epub 2012 Jan 27. Metab Syndr Relat Disord. 2012. PMID: 22283634

5

Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.

Ramachandran S, Saraf S, Shetty C, Capps N, Bailey C. Ramachandran S, et al. Among authors: saraf s. Ann Clin Biochem. 2011 Jan;48(Pt 1):75-8. doi: 10.1258/acb.2010.010081. Epub 2010 Nov 29. Ann Clin Biochem. 2011. PMID: 21115572

6

Fibrates and estimated glomerular filtration rate: observations from an outpatient clinic setting and clinical implications.

Abbas A, Saraf S, Ramachandran S, Raju J, Ramachandran S. Abbas A, et al. Among authors: saraf s. Postgrad Med J. 2012 Sep;88(1043):503-6. doi: 10.1136/postgradmedj-2011-130594. Epub 2012 Mar 29. Postgrad Med J. 2012. PMID: 22460858

7

Prevalence of kidney health genetic variants in adults with sickle cell nephropathy.

Ruiz MA, Zhang X, Mansilla MA, Zahr RS, Thomas CP, Smith RJ, Gordeuk VR, Saraf SL. Ruiz MA, et al. Among authors: saraf sl. Br J Haematol. 2024 May 12. doi: 10.1111/bjh.19525. Online ahead of print. Br J Haematol. 2024. PMID: 38735682

8

Sickle cell disease in India: current status and progress.

Jain D, Gupta M, Madkaikar M, Jena RK, Khargekar N, Saraf SL, Krishnamurti L, Gupta K. Jain D, et al. Among authors: saraf sl. Lancet Haematol. 2024 May;11(5):e322-e323. doi: 10.1016/S2352-3026(24)00109-1. Lancet Haematol. 2024. PMID: 38701819 No abstract available.

9

Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia.

Zahr RS, Rashkin SR, Ruiz MA, Elsherif L, Ren G, Salas G, Ataga KI, Gordeuk VR, Lebensburger J, Zhang X, Saraf SL. Zahr RS, et al. Among authors: saraf sl. Haematologica. 2024 May 2. doi: 10.3324/haematol.2023.284920. Online ahead of print. Haematologica. 2024. PMID: 38695132 Free article.

10

GLP-1 agonists and SGLT-2 inhibitors in adults with sickle cell disease.

Sun R, Srivastava A, Derebail VK, Han J, Molokie RE, Gordeuk V, Saraf SL. Sun R, et al. Among authors: saraf sl. Am J Hematol. 2024 Apr 24. doi: 10.1002/ajh.27348. Online ahead of print. Am J Hematol. 2024. PMID: 38655752 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

601 results

Search Page